Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,894,032 papers from all fields of science
Search
Sign In
Create Free Account
JTT 705
Known as:
JTT-705
, JTT705
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
dalcetrapib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Pharmacokinetics and disposition of dalcetrapib in rats and monkeys
Hiroaki Takubo
,
Tomohiro Ishikawa
,
+5 authors
M. Kogayu
Xenobiotica; the fate of foreign compounds in…
2014
Corpus ID: 207427743
Abstract 1. The pharmacokinetics and metabolism of dalcetrapib (JTT-705/RO4607381), a novel cholesteryl ester transfer protein…
Expand
Review
2012
Review
2012
Therapeutic targets to raise HDL in patients at risk or with coronary artery disease.
T. Lüscher
,
A. von Eckardstein
,
B. Simic
Current Vascular Pharmacology
2012
Corpus ID: 1634122
The plasma levels of high-density lipoprotein (HDL) cholesterol are inversely related to cardiovascular risk. Traditional HDL…
Expand
2009
2009
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia.
F. Hermann
,
F. Enseleit
,
+7 authors
T. Lüscher
Thrombosis Research
2009
Corpus ID: 23703999
2006
2006
Are human CETP mutations and CETP-inhibiting drugs a good or a bad deal?
F. Luft
Journal of molecular medicine
2006
Corpus ID: 7898910
In this issue, Rhyne et al. [1] report on a Greek family harboring novel mutations in the gene encoding the cholesteryl ester…
Expand
Review
2005
Review
2005
Increasing high-density lipoprotein cholesterol through cholesteryl Ester transfer protein inhibition: a next step in the fight against cardiovascular disease?
A. SteegvanderW.
,
Karim El-Harchaoui
,
J. Kuivenhoven
,
John J. P. Kastelein
Current drug targets. Cardiovascular…
2005
Corpus ID: 24001725
Over the past decades, lowering of LDL-cholesterol (LDL-c) levels has been established as the foundation for preventing…
Expand
Review
2004
Review
2004
Role of CETP inhibitors in the treatment of dyslipidemia
W. A. van der Steeg
,
J. Kuivenhoven
,
AH Klerkx
,
S. Boekholdt
,
G. Hovingh
,
J. Kastelein
Current Opinion in Lipidology
2004
Corpus ID: 33636937
Purpose of review This review summarizes novel human data on cholesteryl ester-transfer protein (CETP) and atherosclerosis and…
Expand
2003
2003
Potential therapeutic agents that raise high-density lipoprotein cholesterol levels
Annabelle Rodriguez
,
R. Doshi
2003
Corpus ID: 45254339
Cardiovascular disease remains one of the leading causes of death in westernised societies. A number of risk factors have been…
Expand
2003
2003
Effects of a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, JTT-705, on the Kinetics Properties of HDL in Cholesterol-Fed Rabbits
E. Shimoji
,
Bo Zhang
,
P. Fan
,
K. Saku
2003
Corpus ID: 57281794
Highly Cited
2002
Highly Cited
2002
Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in…
J. Kobayashi
,
H. Okamoto
,
M. Otabe
,
H. Bujo
,
Y. Saito
Atherosclerosis
2002
Corpus ID: 26035609
2002
2002
A CETP Inhibitor, JTT-705, Favorably Affects HDL Particles : Increased Synthesis of Apolipoprotein (Apo) A-I and HDL-Associated Platelet-Activating Factor Acetylhydrolase (PAF-AH)
E. Shimoji
,
Bo Zhang
,
P. Fan
,
K. Saku
2002
Corpus ID: 68361994
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE